Researchers Identify Severe COVID-19 Risk Factors in Young Adults
PLoS One study looks at demographic and clinical markers for severe disease in patients age 18-29. With the age of COVID-19 hospitalizations skewing younger in…
Houston Methodist Research Institute
Lingering Symptoms: Researchers Identify Over 50 Long-Term Effects of COVID-19
Lingering symptoms range from mild to debilitating and last for weeks to months after recovery. As COVID-19 hospitalizations once again soar in a fourth surge…
FDA-Approved Compound Prevents Breast Cancer Cells From Spreading
Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it…
GC-1 Turns White Fat Into Brown Fat
New research shows that the experimental drug GC-1 dramatically increases the metabolic rate, essentially converting white fat into a fat like calorie-burning brown fat. San…